Lower cardiac output measured by echocardiography at study entry predicted faster expansion of the inferior lateral ventricle, a marker of medial temporal tissue loss, over follow-up of up to 11 years, but only in adults carrying the APOE-e4 allele, according to a cohort study published on August 1 in Alzheimer's & Dementia. Elizabeth E. Moore and colleagues at the Vanderbilt Memory and Alzheimer's Center analysed 756 participants of the Vanderbilt Memory and Aging Project, aged 50 to 92 at baseline (mean 67, 47 per cent men, 81 per cent non-Hispanic White), of whom 268 carried at least one APOE-e4 allele and 488 did not. Baseline cardiac output averaged 5.1 litres per minute. Mean imaging follow-up was 4.7 years, and 57 per cent of the sample had more than one visit.

The interaction between baseline cardiac output and APOE-e4 status on change in inferior lateral ventricle volume was statistically significant (beta -30.5 cubic millimetres, p = 0.006). Within carriers, lower cardiac output related to greater ventricular enlargement over time (p = 0.01); within non-carriers there was no association (p = 0.59). Of the two components of cardiac output, lower heart rate showed an association in carriers (beta -3.5, p = 0.04) while stroke volume did not. In cross-sectional models across the whole sample, cardiac output was not related to gray matter volumes and did not interact with APOE-e4 or cognitive status; only in analyses restricted to carriers was lower cardiac output linked to smaller total brain (beta 5768 cubic millimetres, p = 0.02), temporal lobe and occipital lobe volumes.

The cohort was designed to study vascular contributions to brain aging. Participants were recruited in two waves, a 2012 to 2014 group aged 60 and over spanning normal cognition, early mild cognitive impairment and mild cognitive impairment, and a 2021 expansion of cognitively unimpaired adults aged 50 and over; 600 of the 756 were cognitively unimpaired at baseline. Echocardiograms were read by a cardiologist blinded to clinical information, and imaging was processed in core laboratories. The authors' proposed mechanism is oligemia: a heart pumping less blood may leave already vulnerable neurons short of perfusion, an effect they suggest is amplified by APOE-e4's influence on cerebrovascular autoregulation.

The counterpoint sits in the paper itself. The authors write that the results must be interpreted with caution and replicated, and they list the limits: a predominantly White, well-educated and relatively healthy single cohort, which restricts how far the findings travel. Cardiac output was captured once, at baseline. Nearly half the sample contributed only one MRI. Nothing in the design tests whether changing cardiac function changes brain outcomes; a co-author quoted in coverage of the study said prospective work and trials are needed to answer that.